What is your primary (one) diagnosis for this patient at thi

What is your primary (one) diagnosis for this patient at this time?… What is your primary (one) diagnosis for this patient at this time? (support the decision for your diagnosis with pertinent positives and negatives from the case)Primary diagnosis is Allergic Conjunctivitis. This diagnosis is supported by the followingPertinent positives – redness, itching, tearing, slight light sensitivity, intact vision, history of seasonal allergiesPertinent negatives – denies sore throat, no swollen lymph nodes, no fever, no recent illnessIdentify the corresponding ICD-10 code.ICD-10 Code is H10.45Provide a treatment plan for this patient’s primary diagnosis which includes:Medication*Any additional testing necessary for this particular diagnosis*Patient educationReferral Mizoguchi et al. (2017) mention that dual activity medications, are first choice medications for the treatment of allergic conjunctivitis because they are easier tolerated and are more effective in providing symptom relief. As such, pharmacological first line treatment of allergic conjunctivitis includes the use of topical Dual Activity medications – medications that contain antihistamines and mast-cell stabilizing agents. Olopatadine 0.2% (ophthalmic solution), 1 gtt in each affected eye once a day would be prescribed for this patient. Additionally, the effects of intranasal steroids on ocular allergic symptoms have been positive (Dupuis et al., 2020). As such, this patient should continue use of his fluticasone proprionate.   Olopatadine 0.2%Disp: 1 bottleSig: Instill 1 drop into each eye dailyRefills: 0 (If patient requires a new prescription for this medication)Fluticasone Proprionate Nasal Spray 50 mcg per actuationDisp: 1 bottleSig: Use 2 sprays in each nostril dailyRefills: 0  No additional testing is required at this time since this patient is not experiencing any visual disturbances and no foreign body was observed. Patient education: Avoid allergen                              Take your medication as prescribed.                              Wash your hands before and after using this medication.                              Do not touch the container tip to the eye, lid, or other skin.                              Tilt your head back and drop medication into each eye.                              Keep your eyes closed after placing drops and put pressure on the                              inside corner of the eye to keep the medicine in your eye.                              Replace bottle cap after using medicine. Referral to Ophthalmology for possible tonometry studies should be submitted. Dupuis et al. 2020, suggests that ophthalmology referral is required because intranasal steroid use can increase the risk of increased ocular pressure. Provide an active problem list for this patient based on the information given in the case.Active Problem List: Allergic Rhinitis                                 Recreational marijuana use                                 Alcohol use                                 Elevated BMIAre there any changes that you would also make to this patient’s overall treatment plan at this time? Must provide an EBM argument for each treatment or testing decision.At this time, there are no treatment changes that I would employ.Provide an appropriate F/U plan.According to the American Optometric Association, follow up should be based on allergic conjunctivitis severity and the potential for ocular morbidity. A mild case requires a follow up in 5-7 days after initiation of treatment. Consequently, follow up for this patient will be scheduled for 1 week to reassess symptoms and evaluate progress. References  American Optometric Association (n.d.). Optometric Clinical Practice Guidelines: Care of the patient with Conjunctivitis. Retrieved from https://www.sdeyes.org/docs/CPG-11.pdf (Links to an external site.) Dupuis, P., Prokopich, C. L., Hynes, A., & Kim, H. (2020). A contemporary look at allergic conjunctivitis. Allergy, Asthma, and Clinical Immunology, 16(1), 5-5. https://doi.org/10.1186/s13223-020-0403-9 (Links to an external site.) Mizoguchi, T., Ozaki, M., & Ogino, N. (2017). Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment. Clinical Ophthalmology (Auckland, N.Z.), 11, 1747-1753. https://doi.org/10.2147/OPTH.S141279Health Science Science Nursing NURSING NR-511

Let the Experts Do Your Homework Now



Do you have a similar question? Our professional writers have done a similar paper in past.
Give Us your instructions and wait for a professional assignment!

Get a plagiarism-free order today

we guarantee confidentiality and a professional paper and we will meet the deadline.

How it works

  • Paste your instructions in the instructions box. You can also attach an instructions file
  • Select the writer category, deadline, and education level and review the instructions
  • Make a payment for the order to be assigned to a writer
  • Download the paper after the writer uploads it

  • Will the writer plagiarize my essay?
    You will get a plagiarism-free paper and you can get an originality report upon request.

    Is this service safe?
    All personal information is confidential and we have 100% safe payment methods. We also guarantee good grades